Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
News Novavax secures full EU approval for COVID-19 vaccine Nuvaxo... In the first of a double dose of wins for US biotech Novavax, the company has been granted full marketing authorisation (MA) by the
News Janssen's quarterly schizophrenia drug approved in EU Company hopes new formulation will improve patient outcomes.
Digital Chaos & opportunity: Dr Adam Brown unpacks US health policy Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face